UnknownNCT00006319
Molecular and Clinical Studies of Primary Immunodeficiency Diseases
Studying Wiskott-Aldrich syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Human Genome Research Institute (NHGRI)
- Principal Investigator
- Elizabeth K Garabedian, R.N.National Human Genome Research Institute (NHGRI)
- Enrollment
- 266 enrolled
- Eligibility
- 3 years · All sexes
- Timeline
- 2000
Study locations (1)
- National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00006319 on ClinicalTrials.govOther trials for Wiskott-Aldrich syndrome
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07534033Phase II Clinical Study of Probiotic LR607 in Patients With Non-Small Cell Lung CancerZhujiang Hospital
- ACTIVE NOT RECRUITINGPHASE3NCT03837483A Clinical Study to Evaluate the Use of a Cryopreserved Formulation of OTL-103 in Subjects With Wiskott-Aldrich SyndromeFondazione Telethon
- ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT02333760Long Term Safety Follow up of Haematopoietic Stem Cell Gene Therapy for the Wiskott Aldrich SyndromeGenethon